Literature DB >> 10728664

Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway.

T K Kim1, T Kim, T Y Kim, W G Lee, J Yim.   

Abstract

Chemotherapeutic drugs and energy-rich radiation cause DNA damage, inducing signaling pathways for apoptotic cell death or cell growth arrest. The tumor suppressor gene p53 plays the critical role in the regulation of these DNA damage responses. Human tumor cells can become resistant to chemotherapy through functional inactivation of p53. Thus, it is important to identify p53-independent DNA damage signaling pathways. Here, treatment of cells with chemotherapeutic drugs or UV irradiation potentiated the transcriptional activity of IFN regulatory factor-7 (IRF7), inducing its phosphorylation and its nuclear translocation. Furthermore, IRF7 was activated by the c-Jun NH2-terminal kinase (JNK) in response to DNA-damaging agents. Activation of JNK by mitogen-activated protein kinase kinase-4 stimulated the transcriptional activity of IRF7 and induced its translocation into the nucleus. Thus, activation of IRF7 through the JNK signaling pathway may play a role in the transcriptional regulation of genes in response to DNA-damaging agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728664

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Role for p53 in gene induction by double-stranded RNA.

Authors:  B T Hummer; X L Li; B A Hassel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

Review 3.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

4.  Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.

Authors:  Monika Oldak; Liv Tolzmann; Artur Wnorowski; Marta Justyna Podgórska; Steffi Silling; Rongtuan Lin; John Hiscott; Cornelia Sigrid Lissi Müller; Thomas Vogt; Hans Smola; Sigrun Smola
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 5.  Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.

Authors:  Assunta Venuti; Stefan Lohse; Massimo Tommasino; Sigrun Smola
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

6.  Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.

Authors:  Leslie E Huye; Shunbin Ning; Michelle Kelliher; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2007-02-12       Impact factor: 4.272

7.  Coordinate regulation of DNA damage and type I interferon responses imposes an antiviral state that attenuates mouse gammaherpesvirus type 68 replication in primary macrophages.

Authors:  Wadzanai P Mboko; Bryan C Mounce; Brittani M Wood; Joseph M Kulinski; John A Corbett; Vera L Tarakanova
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.

Authors:  Shunbin Ning; Angela M Hahn; Leslie E Huye; Joseph S Pagano
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.

Authors:  Takashi Kumagai; Tadayuki Akagi; Julian C Desmond; Norihiko Kawamata; Sigal Gery; Yasufumi Imai; Jee Hoon Song; Dorina Gui; Jonathan Said; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

Review 10.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.